(Q40604178)
Statements
Recruitment of dendritic cells and enhanced antigen-specific immune reactivity in cancer patients treated with hr-GM-CSF (Molgramostim) and hr-IL-2. results from a phase Ib clinical trial (English)
G Campoccia
K Y Tsang
L Micheli
M Sabatino
G Bruni
S Sestini
R Petrioli
D Pozzessere
S Marsili
G Fanetti
G Giorgi